Abstract P2-06-14: Calcium-Sensing Receptor Agonist Enhanced Anti-Tumor Activity of Adoptive NK Cell Therapy in Triple-Negative Breast Cancer
Lists
Only you see this
Abstract
Abstract Triple-negative breast cancer (TNBC), characterized by the absence of estrogen receptor (ER), progesterone receptor (PR), and human epidermal growth factor receptor 2 (HER-2), often presents a higher infiltration of lymphocytes, suggesting a favorable immune microenvironment for immunotherapy. Recently, natural killer (NK) cells have emerged as a promising option for adoptive cell transfer in cancer immunotherapy. While adoptive NK cell therapy has shown promising efficacy in hematologic malignancies, its practical application in TNBC treatment remains uncertain and variable. Therefore, strategies to enhance the anticancer immune responses of adoptive NK cell therapy in TNBC are urgently needed to improve survival outcomes for TNBC patients. In this study, we explored a novel strategy that combines a calcium-sensing receptor (CaSR) agonist with adoptive NK cell therapy to improve anti-tumor activity in low-response-rate TNBC patient-derived xenograft (PDX) models. Mechanistically, an intracellular Ca2+ imbalance prompted the integration of HLA-DP molecules and circRNA-encoded 296aa, resulting in the retention of HLA-DP intracellularly. The CaSR agonist was observed to aggregate at photodamage sites, leading to ESCRT complex aggregation and membrane repair, which facilitated the budding of HLA-DP-enriched microvesicles. These microvesicles specifically targeted the activating receptor Nkp44 on NK cells, thereby enhancing their cytotoxicity. In vivo experiments further confirmed the efficacy and safety of this combined therapy. These results indicate the feasibility of using adoptive NK cell therapy in combination with a CaSR agonist as an efficient immunotherapy approach for TNBC patients who may be resistant to conventional poly adoptive NK cell therapy. Citation Format: Yu Shi, Qun Lin, Zhuxi Duan, Jinpeng Luo, Jieer Luo, Xiaolin Fang, Chang Gong. Calcium-Sensing Receptor Agonist Enhanced Anti-Tumor Activity of Adoptive NK Cell Therapy in Triple-Negative Breast Cancer [abstract]. In: Proceedings of the San Antonio Breast Cancer Symposium 2024; 2024 Dec 10-13; San Antonio, TX. Philadelphia (PA): AACR; Clin Cancer Res 2025;31(12 Suppl):Abstract nr P2-06-14.
BibTeX
@inproceedings{shi2025abstract,
author = {Yu Shi and Qun Lin and Zhuxi Duan and Jia Luo and Jieer Luo and Xiaolin Fang and Chang Gong},
title = {{Abstract P2-06-14: Calcium-Sensing Receptor Agonist Enhanced Anti-Tumor Activity of Adoptive NK Cell Therapy in Triple-Negative Breast Cancer}},
booktitle = {Clinical},
year = {2025},
doi = {10.1158/1557-3265.sabcs24-p2-06-14},
}Loading related content...